-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CGV4m2zQcgIBTt+hSru/xcvR8jPsz6cBWm/S/tUqiTAwQRxpw/sRbBhHQkoX3n9g Wjn838mZvsOY8GzlYxdBwg== /in/edgar/work/0000927016-00-003466/0000927016-00-003466.txt : 20000930 0000927016-00-003466.hdr.sgml : 20000930 ACCESSION NUMBER: 0000927016-00-003466 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20000921 ITEM INFORMATION: ITEM INFORMATION: FILED AS OF DATE: 20000928 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NMT MEDICAL INC CENTRAL INDEX KEY: 0001017259 STANDARD INDUSTRIAL CLASSIFICATION: [3841 ] IRS NUMBER: 954090463 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 000-21001 FILM NUMBER: 731132 BUSINESS ADDRESS: STREET 1: 27 WORMWOOD STREET CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6177370930 MAIL ADDRESS: STREET 1: 27 WORMWOOD STREET CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: NITINOL MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 19960619 8-K 1 0001.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------------------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 21, 2000 NMT Medical, Inc. - -------------------------------------------------------------------------------- (Exact name of registrant as specified in charter) Delaware 000-21001 95-4090463 - -------------------------------------------------------------------------------- (State or other juris- (Commission (IRS Employer diction of incorporation) File Number) Identification No.) 27 Wormwood Street, Boston, Massachusetts 02210 - -------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (617) 737-0930 N/A - -------------------------------------------------------------------------------- (Former name or former address, if changed since last report) Item 5. Other Events. ------------ On September 25, 2000, NMT Medical, Inc. (the "Company") issued a press release announcing the appointment, effective as of September 21, 2000, of John E. Ahern as President and Chief Executive Officer of the Company. Mr. Ahern will also serve as a member of the Board of Directors and Chairman of the Board. The full text of the Company's press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Item 7. Financial Statements, Pro Forma Financial Information and Exhibits. ------------------------------------------------------------------ (c) Exhibits Exhibit No. Description - ----------- ----------- 99.1 Press Release, dated September 25, 2000, announcing the appointment of John E. Ahern as President and Chief Executive Officer of NMT Medical, Inc. -2- SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 28, 2000 NMT Medical, Inc. ----------------- (Registrant) By: /s/ John E. Ahern ------------------------------------------ Name: John E. Ahern Title: President and Chief Executive Officer -3- EXHIBIT INDEX Exhibit No. Description - ----------- ----------- 99.1 Press Release, dated September 25, 2000, announcing the appointment of John E. Ahern as President and Chief Executive Officer of NMT Medical, Inc. EX-99.1 2 0002.txt PRESS RELEASE DATED SEPTEMBER 25, 2000 Exhibit 99.1 Monday September 25, 11:44 am Eastern Time Press Release SOURCE: NMT Medical, Inc. NMT MEDICAL NAMES JOHN E. AHERN AS PRESIDENT AND CHIEF EXECUTIVE OFFICER ------------------------------------------------------------------------ BOSTON, Sept. 25/ PRNewswire/-- NMT Medical (Nasdaq:NMTI-news) today announced the appointment of Mr. John E. Ahern as President and Chief Executive Officer for the company. Mr. Ahern will also serve the Company as a Director and as Chairman of the Board. Mr. Rudy Davis, Acting President of NMT Medical said, "John is an eminently qualified professional with over 30 years of senior management experience in the medical device business, both in the United States and international markets. His more recent experience and knowledge of the cardiovascular field, particularly in building new markets, will be an important asset to NMT Medical moving forward." Most recently, Mr. Ahern was Vice President, Emerging Technologies at C.R. Bard, Inc., where he was responsible for identifying, investing and managing early- stage emerging technologies and companies. In his 13 years with Bard, Mr. Ahern also held the senior marketing and strategic planning positions in three of the company's cardiovascular divisions. Mr. Ahern's medical device industry experience also includes: IntraSonix, as Vice President of Sales and Marketing; Abbott Laboratories, where he served as Area Manager for the Middle East and North Africa: and Becton Dickinson, where he held positions in sales and marketing. Commenting on today's announcement, Mr. Ahern said, "The minimally-invasive treatment of cardiovascular disease is a large, rapidly growing, worldwide opportunity. NMT Medical has the necessary ingredients to succeed within that opportunity, including an innovative product portfolio, a strong product development pipeline, and a highly talented organization." He concluded by noting, "I look forward to leading NMT in growing the value of the Company and its products across the worldwide cardiovascular marketplace." NMT Medical designs, develops and markets innovative medical devices that utilize advanced technologies and are delivered by minimally invasive procedures. The Company's products are designed to offer alternative approaches to existing complex treatments, thereby reducing patient trauma, shortening procedure, hospitalization and recovery times, and lowering overall treatment costs. The Company's medical devices include self-expanding stents, vena cava filters and septal repair devices. This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties or other factors which may cause actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Factors that might cause such a difference include, but are not limited to, those discussed under the heading "Certain Factors That May Affect Future Results" included in the Management's Discussion and Analysis of Financial Condition and Results of Operations in the Company's Annual Report on Form 10-K for the year ended December 31, 1999 and subsequent filings with the Securities and Exchange Commission. # # # To receive NMT Medical's latest news release and other corporate documents via FAX -- at no cost -- please dial 1-800-PRO-INFO. Enter the Company's symbol NMTI. -----END PRIVACY-ENHANCED MESSAGE-----